Viva Cyte Suite Software Platform

Viva Cyte Suite Software Platform

Viva Cyte Suite Software Platform is an advanced digital ecosystem specifically engineered to revolutionize cell therapy development through the strategic integration of automation, high-throughput analytical capabilities, and sophisticated user experience design principles. Conceived and realized through the collaborative efforts of designers Sara Bianchini, Livia Stevenin, and Agnese Ragucci between January 2022 and August 2024 in Milan, this comprehensive software solution addresses the critical challenges inherent in contemporary biomedical research, particularly within the domain of cancer cell therapy advancement. The platform comprises two synergistic components: Control Software (CSW), which orchestrates the launching and management of biological tests with real-time monitoring capabilities, and Analytical Software (ASW), which extracts, processes, and visualizes meaningful biological insights from experimental data. The design methodology underlying Viva Cyte Suite Software Platform emerged from extensive ethnographic research, including direct observation of biologists in laboratory environments, comprehensive interviews with end-users, and collaborative User Journey Mapping workshops that brought together scientific practitioners and development teams to ensure authentic alignment between technological capabilities and practical laboratory workflows. Built upon a technological foundation utilizing Figma for design conceptualization, React JS for front-end development, and the Bento design system for consistency and scalability, the platform embodies a user-centered design philosophy that prioritizes cognitive load reduction, intuitive navigation architecture, and seamless interaction patterns. The incorporation of artificial intelligence-driven automation represents a significant innovation within the biomedical software landscape, systematically minimizing human error while simultaneously enhancing accuracy and operational efficiency throughout complex experimental protocols. The platform addresses multiple design challenges simultaneously, including the reconciliation of intricate biological workflows with accessible interface design, adherence to stringent medical regulatory compliance standards, and the integration of evolving artificial intelligence capabilities within a framework that remains comprehensible to diverse user populations ranging from research scientists to clinical technicians. Distinctive features include printable laboratory maps, guided setup walkthroughs, and sophisticated data visualization techniques that transform raw experimental outputs into actionable insights, thereby accelerating the therapeutic development pipeline. The scalable architecture ensures adaptability across various research contexts while maintaining consistency in design elements, effective color usage, and attention to micro-interactions that collectively enhance the overall user experience. Viva Cyte Suite Software Platform exemplifies contemporary trends in interface design where aesthetic appeal converges with functional necessity, demonstrating how thoughtful design intervention can materially impact scientific progress and patient care outcomes. The platform received recognition through the Silver A' Design Award in the Interface, Interaction and User Experience Design category in 2025, one of the world's most prestigious design competitions, which acknowledged the work's outstanding expertise, original innovations, and strong technical characteristics that advance the boundaries of design and technology. This accolade specifically recognized the platform's remarkable level of excellence in user experience optimization, visual hierarchy implementation, innovative functionality, accessibility considerations, responsiveness across devices, intuitive navigation design, content clarity, consistency in design elements, feedback mechanism integration, loading time efficiency, aesthetic appeal, data visualization techniques, cognitive load reduction, and integration of motion design. The award designation underscores how Viva Cyte Suite Software Platform represents a tremendously brilliant and exceedingly creative work that benefits the advancement of both design practice and scientific research, demonstrating the profound impact that thoughtful interface design can exert upon specialized professional domains where precision, efficiency, and usability converge to enable breakthrough innovations in healthcare and therapeutic development.

Cell therapy software, biomedical interface design, AI-driven laboratory automation, user experience optimization in healthcare, scientific workflow digitalization, data visualization for biological research

— Adam Dawson

CITATION : "Adam Dawson. 'Viva Cyte Suite Software Platform.' Design+Encyclopedia. https://design-encyclopedia.com/define/viva-cyte-suite-software-platform?E=483863 (Accessed on October 14, 2026)"